Cutaneous neuroendocrine carcinoma is a primary cutaneous cancer arising from a subset of skin neuroendocrine cells (Merkel cells, giving the name Merkel cell carcinoma (MCC)).
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 3, 2026
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Advanced Accelerator Applications, USA
Other
Delcath Systems, Inc.
Other
EntreMed, Inc.
Other
EpicentRx, Inc.
Other
Ipsen Biopharmaceuticals, Inc.
Other
Jubilant DraxImage Inc
Other
Lantheus Medical Imaging, Inc.
Other
M. Sue O'Dorisio, MD, PhD
Other
Mateon Therapeutics, Inc.
Other
Narodowe Centrum Badan Jadrowych
Other
Novartis Pharmaceuticals Corporation
Other
Orano Med Theranostics SAS
Other
Progenics Pharmaceuticals, Inc.
Other
RadioIsotope Therapy of America (RITA) Foundation
Other
RadioMedix Inc.
Other
Seneca Biopharma, Inc.
Other
Tarveda Therapeutics, Inc.
Other
University of Iowa Hospital & Clinics
Other